References

1. Association drepavie. www.drepavie.org. Consulté le 8 Mai 2014.


2. Arnal C, Girot R. Drépanocytose chez l'adulte. Encycl Méd Chir (Éditions Scientifiques et Médicales Elsevier SAS, Paris), Hématologie. 2002 ; 15 p.


3. Redondo MJ, Eisenbarth GS. Genetic control of autoimmunity in type 1 diabetes and associated disorders. Diabetologia. 2002; 45(5): 605-22. PubMed | Google Scholar


4. Ueda H, Howson JMM, Esposito L, Heward J, Snook H, Chamberlain G et al. Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature. 2003; 423(6939): 506-11. PubMed | Google Scholar


5. Lanzkowsky Ph. Manual of pediatric hematology and oncology. academic press. 2000; Third edition: 182-193.


6. Malik S, Syed S, Ahmed N.Complications in transfusion-dependent patients of B-thalassemia major. Pak J Med Sci. 2009;25(4): 678-682. PubMed | Google Scholar


7. Jahantigh M, Naderi M, Dorgalaleh A, Tabibian S. Prevalence of diabetes and impaired glucose tolerance test in patients with thalassemia major. Zahedan J Res Med Sci (ZJRMS). 2014; 16(1): 86-88. PubMed | Google Scholar


8. Moussaif N El, Haddad N El, Iraqi H. Hypercholestérolémie familiale homozygote et drépanocytose: association fortuite ou transmission génétique commune à propos d'un cas. Diabetes et Metabolism. 2011; 37( 1S1): A76 - 177. PubMed | Google Scholar